IONS vs PROF · rev $226.6M vs rev $10.7M
Ionis Pharmaceuticals Inc (IONS) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
IONS currently screens at market cap $12.28B. PROF currently screens at market cap $238.7M.
Not investment advice. Open the IONS and PROF stock pages for the full models.
Not investment advice.